Follow
Dirk Klingbiel
Dirk Klingbiel
Fa. Hoffmann-La Roche Ltd.
Verified email at roche.com
Title
Cited by
Cited by
Year
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial
AD Roth, S Tejpar, M Delorenzi, P Yan, R Fiocca, D Klingbiel, D Dietrich, ...
J Clin Oncol 28 (3), 466-474, 2010
14202010
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
E Missiaglia, B Jacobs, G D'ario, AF Di Narzo, C Soneson, E Budinska, ...
Annals of oncology 25 (10), 1995-2001, 2014
6472014
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer
AD Roth, M Delorenzi, S Tejpar, P Yan, D Klingbiel, R Fiocca, G d’Ario, ...
Journal of the National Cancer Institute 104 (21), 1635-1646, 2012
2902012
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial
D Klingbiel, Z Saridaki, AD Roth, FT Bosman, M Delorenzi, S Tejpar
Annals of oncology 26 (1), 126-132, 2015
2292015
Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis
NR Datta, E Puric, D Klingbiel, S Gomez, S Bodis
International Journal of Radiation Oncology* Biology* Physics 94 (5), 1073-1087, 2016
2052016
Final results of a prospective evaluation of the predictive value of interim positron emission tomography in patients with diffuse large B-cell lymphoma treated with R-CHOP-14 …
C Mamot, D Klingbiel, F Hitz, C Renner, T Pabst, C Driessen, U Mey, ...
Journal of clinical oncology: official journal of the American Society of …, 2015
1842015
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
AJ Templeton, V Dutoit, R Cathomas, C Rothermundt, D Bärtschi, ...
European urology 64 (1), 150-158, 2013
1422013
Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: a systematic review and meta-analysis
NR Datta, E Stutz, M Liu, S Rogers, D Klingbiel, A Siebenhüner, S Singh, ...
Gynecologic oncology 145 (2), 374-385, 2017
1382017
Microsatellite instability (MSI) in stage II and III colon cancer treated with 5FU-LV or 5FU-LV and irinotecan (PETACC 3-EORTC 40993-SAKK 60/00 trial)
S Tejpar, F Bosman, M Delorenzi, R Fiocca, P Yan, D Klingbiel, D Dietrich, ...
Journal of Clinical Oncology 27 (15_suppl), 4001-4001, 2009
1312009
The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster …
F Strasser, D Blum, R Von Moos, R Cathomas, K Ribi, S Aebi, D Betticher, ...
Annals of Oncology 27 (2), 324-332, 2016
1162016
Expression profiling of human idiopathic dilated cardiomyopathy
R Grzeskowiak, H Witt, M Drungowski, R Thermann, S Hennig, A Perrot, ...
Cardiovascular research 59 (2), 400-411, 2003
1102003
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma
C Renner, PL Zinzani, R Gressin, D Klingbiel, PY Dietrich, F Hitz, ...
Haematologica 97 (7), 1085, 2012
1072012
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib …
GA Pesce, D Klingbiel, K Ribi, A Zouhair, R Von Moos, M Schlaeppi, ...
European journal of cancer 48 (3), 377-384, 2012
1072012
Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses
NR Datta, S Rogers, D Klingbiel, S Gómez, E Puric, S Bodis
International Journal of Hyperthermia 32 (7), 809-821, 2016
1042016
Prognostic impact of deficient mismatch repair (dMMR) in 7,803 stage II/III colon cancer (CC) patients (pts): A pooled individual pt data analysis of 17 adjuvant trials in the …
DJ Sargent, Q Shi, G Yothers, S Tejpar, MM Bertagnolli, SN Thibodeau, ...
Journal of Clinical Oncology 32 (15_suppl), 3507-3507, 2014
1022014
A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing
K Matter-Walstra, M Schwenkglenks, S Aebi, K Dedes, J Diebold, ...
Journal of Thoracic Oncology 11 (11), 1846-1855, 2016
962016
Pembrolizumab as palliative immunotherapy in malignant pleural mesothelioma
Y Metaxas, G Rivalland, LA Mauti, D Klingbiel, S Kao, S Schmid, ...
Journal of Thoracic Oncology 13 (11), 1784-1791, 2018
942018
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
S Schmid, S Diem, Q Li, M Krapf, L Flatz, S Leschka, L Desbiolles, ...
Cancer Immunology, Immunotherapy 67, 1825-1832, 2018
902018
Activity of platinum-based chemotherapy in patients with advanced prostate cancer with and without DNA repair gene aberrations
S Schmid, A Omlin, C Higano, C Sweeney, NM Chanza, N Mehra, ...
JAMA network open 3 (10), e2021692-e2021692, 2020
792020
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical …
D Juskevicius, D Jucker, D Klingbiel, C Mamot, S Dirnhofer, A Tzankov
Journal of hematology & oncology 10, 1-10, 2017
792017
The system can't perform the operation now. Try again later.
Articles 1–20